NO931225L - Benzoksazinon- og benzotiazinon-derivater med kardiovaskulaer akrivitet - Google Patents

Benzoksazinon- og benzotiazinon-derivater med kardiovaskulaer akrivitet

Info

Publication number
NO931225L
NO931225L NO93931225A NO931225A NO931225L NO 931225 L NO931225 L NO 931225L NO 93931225 A NO93931225 A NO 93931225A NO 931225 A NO931225 A NO 931225A NO 931225 L NO931225 L NO 931225L
Authority
NO
Norway
Prior art keywords
benzotiazinon
benzoksazinon
acrivity
cardiovascular
derivatives
Prior art date
Application number
NO93931225A
Other languages
English (en)
Norwegian (no)
Other versions
NO931225D0 (no
Inventor
Alberto Sala
Francesca Benedini
Roberto Barani
Giorgio Bartolini
Giancarlo Dona
Gianni Gromo
Silvio Levi
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of NO931225D0 publication Critical patent/NO931225D0/no
Publication of NO931225L publication Critical patent/NO931225L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/201,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/041,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/081,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Control Of Transmission Device (AREA)
  • Optical Filters (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO93931225A 1992-04-16 1993-03-31 Benzoksazinon- og benzotiazinon-derivater med kardiovaskulaer akrivitet NO931225L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI920940A IT1254884B (it) 1992-04-16 1992-04-16 Benzossazinoni e benzotiazinoni ad attivita' cardiovascolare

Publications (2)

Publication Number Publication Date
NO931225D0 NO931225D0 (no) 1993-03-31
NO931225L true NO931225L (no) 1993-10-18

Family

ID=11362985

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93931225A NO931225L (no) 1992-04-16 1993-03-31 Benzoksazinon- og benzotiazinon-derivater med kardiovaskulaer akrivitet

Country Status (17)

Country Link
US (1) US5480882A (ja)
EP (1) EP0566018B1 (ja)
JP (1) JP3257716B2 (ja)
CN (1) CN1078466A (ja)
AT (1) ATE169293T1 (ja)
AU (1) AU655540B2 (ja)
CA (1) CA2092342A1 (ja)
DE (1) DE69320087T2 (ja)
FI (1) FI931688A (ja)
HU (1) HUT68605A (ja)
IL (1) IL105158A (ja)
IT (1) IT1254884B (ja)
MX (1) MX9302165A (ja)
NO (1) NO931225L (ja)
NZ (1) NZ247249A (ja)
TW (1) TW288013B (ja)
ZA (1) ZA932030B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264812B1 (it) * 1993-07-28 1996-10-10 Italfarmaco Spa Derivati benzossazinonici e benzotiazinonici terapeuticamente attivi
WO2001004103A1 (en) 1999-07-13 2001-01-18 F. Hoffmann-La Roche Ag Benzazepinones and quinazolines
WO2002018356A1 (fr) * 2000-08-31 2002-03-07 Takeda Chemical Industries, Ltd. Inhibiteurs de l'apoptose des cellules du muscle cardiaque et agents therapeutiques/prophylactiques contre les maladies cardiaques
JP5700547B2 (ja) 2011-05-30 2015-04-15 国立大学法人京都大学 バイオチップ形成用感光性樹脂組成物、及びバイオチップ
CN102367239B (zh) * 2011-07-20 2015-10-28 沈阳药科大学 2-芳基-2,3-二氢-4h-1,3-苯并噻嗪-4-酮衍生物及其用途
CN103012188A (zh) * 2011-09-20 2013-04-03 北京京卫信康医药科技发展有限公司 一种龙胆酸乙醇胺的制备方法
CN102631108A (zh) * 2012-04-25 2012-08-15 张家港市立达金属制品有限公司 帽子展示架
ITMI20122221A1 (it) * 2012-12-21 2014-06-22 C4T S C A R L Nuovi composti del 2,3-diidro-4h-1,3-benzossazin-4-one, metodo per prepararli e forma farmaceutica che li comprende

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3539563A (en) * 1965-09-27 1970-11-10 Istituto Chemioterapico Tetracycline: 6-amino-4-oxo-2-(beta-chloroethyl) - 2,3 - dihydrobenzene - 1,3-oxazine double salt dihydrate
US3459748A (en) * 1967-04-28 1969-08-05 Squibb & Sons Inc Hydroxyalkylene-substituted benzoxazines and benzothiazines
FR2636065B1 (fr) * 1988-09-08 1993-05-07 Fabre Sa Pierre Nouveaux derives de dihydro-2,3 arylacoylaminoalcoyl-3 4h-benzoxazine-1,3 ones-4, leur preparation et leur application en tant que medicaments utiles en therapeutique
IT1244472B (it) * 1990-12-14 1994-07-15 Italfarmaco Spa Benzossazinoni e benzotiazinoni ad attivita' cardiovascolare

Also Published As

Publication number Publication date
US5480882A (en) 1996-01-02
DE69320087T2 (de) 1998-12-10
EP0566018B1 (en) 1998-08-05
CN1078466A (zh) 1993-11-17
AU3561793A (en) 1993-10-21
TW288013B (ja) 1996-10-11
NZ247249A (en) 1995-01-27
EP0566018A3 (en) 1994-06-01
ATE169293T1 (de) 1998-08-15
HU9301106D0 (en) 1993-07-28
FI931688A (fi) 1993-10-17
DE69320087D1 (de) 1998-09-10
FI931688A0 (fi) 1993-04-14
EP0566018A2 (en) 1993-10-20
ITMI920940A0 (it) 1992-04-16
JP3257716B2 (ja) 2002-02-18
ZA932030B (en) 1993-10-19
JPH0625194A (ja) 1994-02-01
IT1254884B (it) 1995-10-11
CA2092342A1 (en) 1993-10-17
MX9302165A (es) 1993-10-01
AU655540B2 (en) 1994-12-22
ITMI920940A1 (it) 1993-10-16
NO931225D0 (no) 1993-03-31
HUT68605A (en) 1995-06-28
IL105158A (en) 1996-10-31

Similar Documents

Publication Publication Date Title
DE3588100D1 (de) Carbamidsäureester-Derivate, Mittel und Herstellungsverfahren
AU537414B2 (en) Pyroglutamic acid derivatives
DK345989D0 (da) Quinolinderivater
NO942452D0 (no) Amid- og ureaderivater med antihyperkolesteremisk aktivitet, deres fremstilling og terapeutiske anvendelser
FI862757A0 (fi) Pyridonkarbonsyraderivat och foerfarande foer framstaellning av dessa.
LU91031I2 (en) Zaxem
NO931225L (no) Benzoksazinon- og benzotiazinon-derivater med kardiovaskulaer akrivitet
IS3828A (is) Hliðstæð aðferð til tilreiðslu á nýjum afleiðum thiazolidinone og oxazolidinone sem gagnlegar eru til æðaútvíkkunar
NO895198L (no) Fremgangsmaate for fremstilling av 4,5,6,7-tetrahydrobenzimidazolderivater.
DK0417790T3 (da) S-triazolo(3,4-i)purin-derivater
DE3561153D1 (de) Benzoylurea derivatives
IT1241988B (it) 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono
ES8603806A1 (es) Procedimiento para preparar nuevas n-(naftilalquil)-hidroxi-laminas
ES2055094T3 (es) Utilizacion de poliaminas oxidadas, en particular nn'-bis-(3-propionaldehido)-1-4-diaminobutano (dialdehido espermina) como agentes inmunosupresores.
FI955680A0 (fi) Psoraleenijohdannaiset, niiden valmistus ja käyttö
ES2039270T3 (es) Derivados de gamma-l-glutamil-4-nitroanilida y procedimiento para determinar actividad de gamma-gtp utilizandolos.
ATE40998T1 (de) Thiophenonderivate sowie verfahren zu deren herstellung.
ES8707500A1 (es) Procedimiento para la obtencion de isocianatos piperidinicos.
GEP19970664B (en) Acrylic acid derivatives and stereoisomers